United States · FDA National Drug Code directory

Ciprofloxacin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
76420-045_50958031-77c0-2b97-e063-6394a90a2c43
Product NDC
76420-045
Form
TABLET, FILM COATED
Composition / generic term
Ciprofloxacin Hydrochloride
Labeler
Asclemed USA, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20070426 / 20261031

Source-listed ingredients

  • CIPROFLOXACIN HYDROCHLORIDE — 500 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 6 TABLET, FILM COATED in 1 BOTTLE (76420-045-06) · 76420-045-06
  • 10 TABLET, FILM COATED in 1 BOTTLE (76420-045-10) · 76420-045-10
  • 14 TABLET, FILM COATED in 1 BOTTLE (76420-045-14) · 76420-045-14
  • 20 TABLET, FILM COATED in 1 BOTTLE (76420-045-20) · 76420-045-20
  • 30 TABLET, FILM COATED in 1 BOTTLE (76420-045-30) · 76420-045-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Ciprofloxacin — United States | Molindra Medicines